Instant Reaction: Paramount CEO Bob Bakish Is Out

Instant Reaction: Paramount CEO Bob Bakish Is...

Up next

Vir Bio's Cancer Treatment Progress Driving Shares Hight

Vir Biotechnology Vir is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. The company on Monday announced new data from the ongoing Phase 1 clini ...  Show more

Introducing: Bloomberg This Weekend

'Bloomberg This Weekend' features unique conversations on business, news, lifestyle and culture. Join David Gura, Christina Ruffini and Lisa Mateo Saturdays and Sundays for discussions with business leaders, lawmakers and cultural icons. Watch the show LIVE on Bloomberg Televisio ...  Show more

Recommended Episodes

CG: Can Papa John’s New CEO Turn the Company Around?
Industry Focus

Last week, Papa John’s hired Arby’s President Rob Lynch as its new CEO. This continues an ongoing evolution of the company as it moves on from its relationship with founder John Schnatter. Motley Fool Contributor Dan Kline joins the show to discuss the hire and how it fits into t ...  Show more

159. Voices of CEO Excellence: Merck’s Ken Frazier. Episode 1
Inside the Strategy Room

As CEO of Merck, Ken Frazier gained the respect of his employees, shareholders, and the broader community - both through the company’s performance during his 11-year tenure and also through his handling of several tests of his leadership.

Now Merck’s former executive c ...

  Show more

3 CEOs Walk Into A Bar...
Motley Fool Money

It's CEO Day! (Ok, not really, but CEOs were very much in the news today.) (0:21) Jason Moser discusses: - Target eliminating a long-standing policy to extend Brian Cornell's job as CEO for 3 more years - Starbucks' plan to spend the next six months onboarding CEO-in-waiting Lax ...  Show more

160. Voices of CEO Excellence: Merck's Ken Frazier. Episode 2.
Inside the Strategy Room

In this second episode of our Voices of CEO Excellence interview with Ken Frazier, the former executive chairman and CEO of Merck candidly reflects on how he managed past crises.

Frazier discusses his decision-making process around the litigation trial concerning Merck’ ...

  Show more